{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:08:30Z","timestamp":1784070510979,"version":"3.55.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012483","name":"University of Georgia Research Foundation","doi-asserted-by":"publisher","award":["BAP-2022-1-TP3-4580"],"award-info":[{"award-number":["BAP-2022-1-TP3-4580"]}],"id":[{"id":"10.13039\/100012483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins & Other Lipid Mediators"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.prostaglandins.2024.106918","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T12:55:50Z","timestamp":1729774550000},"page":"106918","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Protection by selective mTORC2 inhibition of Zymosan-induced hypotension and systemic inflammation mediated via IKK\u03b1\/I\u03baB-\u03b1\/NF-\u03baB activation"],"prefix":"10.1016","volume":"175","author":[{"given":"Zainab","family":"Sabrie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryem","family":"Temiz-Resitoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taskin","family":"Kalkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu","family":"Kilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahar","family":"Tunctan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kafait U.","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyhan","family":"Sahan-Firat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prostaglandins.2024.106918_bib1","first-page":"191","article-title":"Role of interleukin-6 in a non-septic shock model induced by Zymosan","volume":"10","author":"Cuzzocrea","year":"1999","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.prostaglandins.2024.106918_bib2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00024382-200116010-00010","article-title":"Inducible nitric oxide synthase knockout mice exhibit resistance to the multiple organ failure induced by Zymosan","volume":"16","author":"Cuzzocrea","year":"2001","journal-title":"Shock"},{"issue":"49","key":"10.1016\/j.prostaglandins.2024.106918_bib3","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1038\/sj.onc.1203239","article-title":"Activators and target genes of Rel\/NF-\u03baB transcription factors","volume":"18","author":"Pahl","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.prostaglandins.2024.106918_bib4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1096\/fasebj.15.1.2","article-title":"Inhibition of NF-{kappa}B and AP-1 activation by R- and S-flurbiprofen.","volume":"15","author":"Tegeder","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.prostaglandins.2024.106918_bib5","doi-asserted-by":"crossref","first-page":"9409","DOI":"10.1073\/pnas.96.16.9409","article-title":"Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis","volume":"96","author":"Kaltschmidt","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prostaglandins.2024.106918_bib6","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1172\/JCI118598","article-title":"Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion","volume":"97","author":"Brand","year":"1996","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.prostaglandins.2024.106918_bib7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrc780","article-title":"NF-kappaB in cancer: from innocent bystander to major culprit.","volume":"2","author":"Karin","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prostaglandins.2024.106918_bib8","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1126\/science.281.5381.1360","article-title":"Direct phosphorylation of IkappaB by IKKalpha and IKKbeta: discrimination between free and NF-kappaB-bound substrate","volume":"281","author":"Zandi","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.prostaglandins.2024.106918_bib9","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/41493","article-title":"A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB.","volume":"388","author":"DiDonato","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.prostaglandins.2024.106918_bib10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/26261","article-title":"IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex.","volume":"395","author":"Rothwarf","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.prostaglandins.2024.106918_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejphar.2017.02.034","article-title":"Activation of mTOR\/I\u03baB-\u03b1\/NF-\u03baB pathway contributes to LPS-induced hypotension and inflammation in rats","volume":"802","author":"Temiz-Resitoglu","year":"2017","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.prostaglandins.2024.106918_bib12","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s10753-017-0686-2","article-title":"Protection by mTOR inhibition on zymosan-induced systemic inflammatory response and oxidative\/nitrosative stress: contribution of mTOR\/MEK1\/ERK1\/2\/IKK\u03b2\/I\u03baB-\u03b1\/NF-\u03baB signalling pathway","volume":"41","author":"Sahan-Firat","year":"2018","journal-title":"Inflammation"},{"issue":"2","key":"10.1016\/j.prostaglandins.2024.106918_bib13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/1440-1681.12864","article-title":"The role of Syk\/I\u0138B-\u03b1\/NF-\u0138B pathway activation in the reversal effect of BAY 61-3606, a selective Syk inhibitor, on hypotension and inflammation in a rat model of zymosan-induced non-septic shock","volume":"45","author":"Unsal","year":"2018","journal-title":"Clin. Exp. Pharm. Physiol."},{"key":"10.1016\/j.prostaglandins.2024.106918_bib14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.devcel.2007.03.020","article-title":"The two TORCs and AKT","volume":"12","author":"Bhaskar","year":"2007","journal-title":"Dev. Cell"},{"key":"10.1016\/j.prostaglandins.2024.106918_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1042\/BJ20071518","article-title":"TOR regulation of AGC kinases in yeast and mammals","volume":"410","author":"Jacinto","year":"2008","journal-title":"Biochem J."},{"key":"10.1016\/j.prostaglandins.2024.106918_bib16","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.cellsig.2009.01.012","article-title":"Mammalian target of rapamycin complex 1: signalling inputs, substrates and feedback mechanisms","volume":"21","author":"Dunlop","year":"2009","journal-title":"Cell Signal"},{"key":"10.1016\/j.prostaglandins.2024.106918_bib17","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.tibs.2009.09.004","article-title":"TOR complex 2: a signaling pathway of its own","volume":"34","author":"Cybulski","year":"2009","journal-title":"Trends Biochem Sci."},{"issue":"27","key":"10.1016\/j.prostaglandins.2024.106918_bib18","article-title":"New insights into mTOR signaling: mTORC2 and beyond","volume":"2","author":"Alessi","year":"2009","journal-title":"Sci. Signal"},{"key":"10.1016\/j.prostaglandins.2024.106918_bib19","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1242\/jcs.051011","article-title":"mTOR signaling at a glance","volume":"122","author":"Laplante","year":"2009","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.prostaglandins.2024.106918_bib20","doi-asserted-by":"crossref","first-page":"40406","DOI":"10.1074\/jbc.M508361200","article-title":"mTOR\u00b7RICTOR is the Ser473 kinase for Akt\/protein kinase B in 3T3-L1 adipocytes","volume":"280","author":"Hresko","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prostaglandins.2024.106918_bib21","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.prostaglandins.2024.106918_bib22","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1002\/jcp.26276","article-title":"Therapeutic potency of mTOR signaling pharmacological inhibitors in the treatment of pro-inflammatory diseases, current status, and perspectives.","volume":"233","author":"Soltani","year":"2018","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.prostaglandins.2024.106918_bib23","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nri2546","article-title":"Immunoregulatory functions of mTOR inhibition","volume":"9","author":"Thomson","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.prostaglandins.2024.106918_bib24","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.immuni.2008.08.012","article-title":"The TSC-mTOR signaling pathway regulates the innate inflammatory response","volume":"29","author":"Weichhart","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.prostaglandins.2024.106918_bib25","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nri3901","article-title":"Regulation of innate immune cell function by mTOR","volume":"15","author":"Weichhart","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.prostaglandins.2024.106918_bib26","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1139\/cjpp-2020-0487","article-title":"mTOR inhibition as a possible pharmacological target in the management of systemic inflammatory response and associated neuroinflammation by lipopolysaccharide challenge in rats","volume":"99","author":"Guden","year":"2021","journal-title":"Can. J. Physiol. Pharm."},{"key":"10.1016\/j.prostaglandins.2024.106918_bib27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/1440-1681.13045","article-title":"NF-\u03baB activation mediates LPS or Zymosan induced hypotension and inflammation reversed by BAY 61-3606, a selective Syk inhibitor, in rat models of septic and non-septic shock","volume":"46","author":"Sahan-Firat","year":"2019","journal-title":"Clin. Exp. Pharm. Physiol."},{"key":"10.1016\/j.prostaglandins.2024.106918_bib28","doi-asserted-by":"crossref","first-page":"52685","DOI":"10.18632\/oncotarget.10943","article-title":"The underlying mechanism of pro-inflammatory NF-\u03baB activation by the mTORC2\/Akt\/IKK\u03b1 pathway during skin aging.","volume":"7","author":"Choi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prostaglandins.2024.106918_bib29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.biochi.2018.06.001","article-title":"Inflammation-induced mTORC2-Akt-mTORC1 signaling promotes macrophage foam cell formation","volume":"151","author":"Banerjee","year":"2018","journal-title":"Biochimie"},{"issue":"10","key":"10.1016\/j.prostaglandins.2024.106918_bib30","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/all.13152","article-title":"mTORC2 controls Th9 polarization and allergic airway inflammation","volume":"72","author":"Chen","year":"2017","journal-title":"Allergy"},{"issue":"15","key":"10.1016\/j.prostaglandins.2024.106918_bib31","doi-asserted-by":"crossref","DOI":"10.1172\/JCI152635","article-title":"mTORC2 mediates structural plasticity in distal nociceptive endings that contributes to pain hypersensitivity following inflammation","volume":"132","author":"Wong","year":"2022","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.prostaglandins.2024.106918_bib32","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s10753-016-0483-3","article-title":"Inhibition of NLRP3 Inflammasome Prevents LPS-Induced Inflammatory Hyperalgesia in Mice: Contribution of NF-\u03baB, Caspase-1\/11, ASC, NOX, and NOS Isoforms","volume":"40","author":"Dolunay","year":"2017","journal-title":"Inflammation"},{"key":"10.1016\/j.prostaglandins.2024.106918_bib33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.prostaglandins.2013.01.005","article-title":"5,14-HEDGE, a 20-HETE mimetic, reverses hypotension and improves survival in a rodent model of septic shock: Contribution of soluble epoxide: hydrolase, CYP2C23, MEK1\/ERK1\/2\/IKK beta\/IKB-alpha.\/NF-kappa B pathway, and pro-inflammatory","volume":"102","author":"Tunctan","year":"2013","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.prostaglandins.2024.106918_bib34","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem"},{"issue":"4","key":"10.1016\/j.prostaglandins.2024.106918_bib35","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00024382-199710000-00006","article-title":"Multiple organ failure following zymosan-induced peritonitis is mediated by nitric oxide","volume":"8","author":"Cuzzocrea","year":"1997","journal-title":"Shock"},{"issue":"2","key":"10.1016\/j.prostaglandins.2024.106918_bib36","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1476-5381.1991.tb12468.x","article-title":"Dissociation between the effects of Zymosan on the systemic and pulmonary vessels of the rat","volume":"104","author":"Damas","year":"1991","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.prostaglandins.2024.106918_bib37","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1073\/pnas.87.9.3629","article-title":"NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide","volume":"87","author":"Kilbourn","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.prostaglandins.2024.106918_bib38","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1006\/jsre.2001.6087","article-title":"The effect of nitric oxide inhibition on blood pressure depends on rat strain","volume":"96","author":"Forster","year":"2001","journal-title":"J. Surg. Res"},{"issue":"6","key":"10.1016\/j.prostaglandins.2024.106918_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102683","article-title":"NFAT signaling in human mesenchymal stromal cells affects extracellular matrix remodeling and antifungal immune responses","volume":"24","author":"Tidu","year":"2021","journal-title":"Iscience"},{"issue":"4","key":"10.1016\/j.prostaglandins.2024.106918_bib40","doi-asserted-by":"crossref","first-page":"a000034","DOI":"10.1101\/cshperspect.a000034","article-title":"The NF-\u03baB family of transcription factors and its regulation","volume":"1","author":"Oeckinghaus","year":"2009","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"4","key":"10.1016\/j.prostaglandins.2024.106918_bib41","doi-asserted-by":"crossref","first-page":"L622","DOI":"10.1152\/ajplung.00477.2005","article-title":"NF-\u03baB activation as a pathological mechanism of septic shock and inflammation","volume":"290","author":"Liu","year":"2006","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"2","key":"10.1016\/j.prostaglandins.2024.106918_bib42","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0092-8674(02)00703-1","article-title":"Missing pieces in the NF-\u03baB puzzle","volume":"109","author":"Ghosh","year":"2002","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.prostaglandins.2024.106918_bib43","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.phrs.2009.09.008","article-title":"PD98059, a specific MAP kinase inhibitor, attenuates multiple organ dysfunction syndrome\/failure (MODS) induced by Zymosan in mice","volume":"61","author":"Di Paola","year":"2010","journal-title":"Pharm. Res"},{"issue":"6","key":"10.1016\/j.prostaglandins.2024.106918_bib44","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1158\/2159-8290.CD-11-0124","article-title":"Oncogenic EGFR signaling activates an mTORC2\u2013NF-\u03baB pathway that promotes chemotherapy resistance","volume":"1","author":"Tanaka","year":"2011","journal-title":"Cancer Discov."},{"issue":"16","key":"10.1016\/j.prostaglandins.2024.106918_bib45","doi-asserted-by":"crossref","first-page":"21064","DOI":"10.18632\/oncotarget.8383","article-title":"PI3K\/Akt promotes feedforward mTORC2 activation through IKK\u03b1","volume":"7","author":"Dan Han","year":"2016","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.prostaglandins.2024.106918_bib46","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.acthis.2012.02.004","article-title":"The expression of iNOS and nitrotyrosine in colitis and colon cancer in humans","volume":"114","author":"Gochman","year":"2012","journal-title":"Acta Histochem"},{"issue":"5","key":"10.1016\/j.prostaglandins.2024.106918_bib47","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1089\/089771501300227323","article-title":"iNOS and nitrotyrosine expression after spinal cord injury","volume":"18","author":"Xu","year":"2001","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.prostaglandins.2024.106918_bib48","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0166-2236(93)90109-Y","article-title":"Synthesis of nitric oxide in CNS glial cells","volume":"16","author":"Murphy","year":"1993","journal-title":"Trends Neurosci."},{"issue":"7","key":"10.1016\/j.prostaglandins.2024.106918_bib49","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1167\/iovs.13-11796","article-title":"Regulation of iNOS expression by NF-\u03baB in human lens epithelial cells treated with high levels of glucose","volume":"54","author":"Jia","year":"2013","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.prostaglandins.2024.106918_bib50","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s000110050728","article-title":"Role of nitric oxide in Zymosan induced paw inflammation and thermal hyperalgesia","volume":"50","author":"Guhring","year":"2001","journal-title":"Inflamm. Res"},{"key":"10.1016\/j.prostaglandins.2024.106918_bib51","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1006\/bbrc.1994.1542","article-title":"A rapid and simple method for the measurement of nitrite and nitrate in plasma by high performance capillary electrophoresis","volume":"200","author":"Leone","year":"1994","journal-title":"Biochem Biophys. Res Comm."},{"issue":"3","key":"10.1016\/j.prostaglandins.2024.106918_bib52","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1124\/jpet.108.149336","article-title":"Cyclooxygenase-2 induced by Zymosan in human monocyte-derived dendritic cells shows high stability, and its expression is enhanced by atorvastatin","volume":"329","author":"Alvarez","year":"2009","journal-title":"J. Pharm. Exp. Ther."},{"issue":"3","key":"10.1016\/j.prostaglandins.2024.106918_bib53","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/labinvest.3780243","article-title":"Nuclear factor-\u03baB regulates cyclooxygenase-2 expression and cell proliferation in human gastric cancer cells","volume":"81","author":"Lim","year":"2001","journal-title":"Lab Invest"},{"issue":"5","key":"10.1016\/j.prostaglandins.2024.106918_bib54","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0090-6980(85)90006-1","article-title":"Intraperitoneal injection of zymosan in mice induces pain, inflammation and the synthesis of peptidoleukotrienes and prostaglandin E2","volume":"30","author":"Doherty","year":"1985","journal-title":"Prostaglandins"},{"key":"10.1016\/j.prostaglandins.2024.106918_bib55","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.iy.12.040194.001041","article-title":"Function and activation of NF-kappa B in the immune system","volume":"12","author":"Baeuerle","year":"1994","journal-title":"Annu Rev. Immunol."},{"key":"10.1016\/j.prostaglandins.2024.106918_bib56","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1074\/jbc.272.1.601","article-title":"Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells","volume":"272","author":"Schmedtje","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prostaglandins.2024.106918_bib57","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.bcp.2006.06.029","article-title":"Inflammation and cancer: how hot is the link?","volume":"72","author":"Aggarwal","year":"2006","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.prostaglandins.2024.106918_bib58","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/01.shk.0000235084.56100.71","article-title":"Glycogen synthase kinase 3\u03b2 inhibition reduces the development of non-septic shock induced by Zymosan in mice","volume":"27","author":"Cuzzocrea","year":"2007","journal-title":"Shock"},{"key":"10.1016\/j.prostaglandins.2024.106918_bib59","doi-asserted-by":"crossref","DOI":"10.1186\/ar1494","article-title":"TLR2 modulates inflammation in zymosan-induced arthritis in mice","volume":"7","author":"Frasnelli","year":"2005","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.prostaglandins.2024.106918_bib60","first-page":"58","article-title":"Zymosan A an Old Tool in Experimental Pharmacology with Newer Applications","volume":"4","author":"Dharavath","year":"2017","journal-title":"Curr. Res Diab Obes. J."},{"issue":"4","key":"10.1016\/j.prostaglandins.2024.106918_bib61","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-3083.1990.tb02925.x","article-title":"Tumour Necrosis Factor Alpha (TNF-\u03b1) and Interleukin 6 in a Zymosan-Induced Shock Model","volume":"32","author":"Von Asmuth","year":"1990","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.prostaglandins.2024.106918_bib62","article-title":"Effects of melatonin and 5-methoxytryptophol on synovial inflammation in the zymosan-induced rheumatoid arthritis in rats","author":"Savtekin","year":"2016","journal-title":"Int J. Clin. Exp. Med"},{"key":"10.1016\/j.prostaglandins.2024.106918_bib63","series-title":"Pharmacotherapy","first-page":"1943","article-title":"Sepsis and septic shock","author":"Kang-Birken","year":"2008"},{"issue":"2","key":"10.1016\/j.prostaglandins.2024.106918_bib64","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/cea.12805","article-title":"Calpain-activated mTORC2\/Akt pathway mediates airway smooth muscle remodelling in asthma","volume":"47","author":"Rao","year":"2017","journal-title":"Clin. Exp. Allergy"},{"issue":"45","key":"10.1016\/j.prostaglandins.2024.106918_bib65","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ebiom.2019.06.052","article-title":"mTORC2\/Akt activation in adipocytes is required for adipose tissue inflammation in tuberculosis","volume":"1","author":"Martinez","year":"2019","journal-title":"EBioMedicine"}],"container-title":["Prostaglandins & Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882324001126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882324001126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:51:02Z","timestamp":1784069462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882324001126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":65,"alternative-id":["S1098882324001126"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2024.106918","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protection by selective mTORC2 inhibition of Zymosan-induced hypotension and systemic inflammation mediated via IKK\u03b1\/I\u03baB-\u03b1\/NF-\u03baB activation","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2024.106918","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106918"}}